Apexigen, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Apexigen, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2021 to Q4 2022.
  • Apexigen, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $44.5M, a 37.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $44.5M +$12.1M +37.4% Dec 31, 2022 10-K 2023-02-22
Q4 2021 $32.4M Dec 31, 2021 10-K 2023-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.